Our Mission Statement
WellTree’s mission is to further, promote and deliver novel rapid diagnostic tests to point-of-care environments to aid in better patient outcomes while driving time and costs down.
Our Team
WellTree is founded by health care operation professionals with experience and understanding of the complexities of healthcare. Our commitment to excellence and innovation is the guiding philosophy of the team.
Renee M. Marchand Pharm D. -- Chief Executive Officer
Renee works closely with emerging medical device innovators and manufacturers to find a space in the marketplace for the value they bring to doctors, patients, and communities. Renee has 10 plus years of experience in the field both as a pharmacist and business manager.
Ann Flamm, CPhT, NCPT -- Chief Operating Officer
Ann’s years of experience in Pharmacy has established her with knowledge on Federal and State compliance requirements for Healthcare and has maintained great relationships with regulatory representatives. Ann is charged with maintaining complete and accurate tracking records for all medical device sales.
Advisory Board
Szilard Voros, MD, FAAC, FSCCT, FAHA
Dr. Voros is the Founder and CEO of Global Genomics Group (“G3”), a precision-medicine-based biotechnology company, developing and commercializing diagnostic biomarkers and novel drug targets for common diseases. G3’s platform is based on the largest-ever program using DNA and RNA sequencing, proteomics, metabolomics, lipidomic and other platforms. He has published extensively in Nature Reviews, New England Journal of Medicine and Annals of Internal Medicine.